Sun Pharma to acquire Organon in USD 11.75 billion deal
Sun Pharma→Organon
Apr 28, 2026

Channel-specific outreach playbooks for deal origination.
Comparison posts, methodology, and analysis from the Tentt team.
Monthly market reports on M&A and private equity activity.
Free calculators for M&A, lending, and deal analysis.
Origination in the Age of AI.
Johnson & Johnson has acquired Atraverse Medical, a medical devices business in the United States. Atraverse Medical develops and commercializes healthcare medical device technologies, supporting clinical workflows and patient care. Johnson & Johnson acquisitions in medical devices acquisition categories often focus on expanding product capabilities and strengthening strategic acquisition pipelines in key markets. This other acquisition is announced and structured as a strategic acquisition by a corporate buyer, with deal size undisclosed and terms not publicly specified.
Source
Read full article on todaysmedicaldevelopments.comvia GN - entered into definitive agreement · April 27, 2026
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Sun Pharma→Organon
Apr 28, 2026
Sun Pharma→Organon
Apr 28, 2026
IMG Pharma→Matsumoto Pharmaceutical
Apr 27, 2026
TPG→Optum UK
Apr 27, 2026
Sun Pharma→Organon
Apr 27, 2026